Corcept Therapeutics Inc (NASDAQ: CORT) on Friday, plunged -3.06% from the previous trading day, before settling in for the closing price of $73.1. Within the past 52 weeks, CORT’s price has moved between $32.33 and $117.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.89%. The company achieved an average annual earnings per share of 11.99%. With a float of $93.80 million, this company’s outstanding shares have now reached $105.98 million.
Considering the fact that the conglomerate employs 500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 98.43%, operating margin of 16.17%, and the pretax margin is 19.86%.
Corcept Therapeutics Inc (CORT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Corcept Therapeutics Inc is 11.55%, while institutional ownership is 78.63%. The most recent insider transaction that took place on Jul 17 ’25, was worth 2,914,000. Before that another transaction happened on Jul 10 ’25, when Company’s Director sold 2,200 for $71.08, making the entire transaction worth $156,376. This insider now owns 0 shares in total.
Corcept Therapeutics Inc (CORT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 11.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 69.48% during the next five years compared to 9.89% growth over the previous five years of trading.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Corcept Therapeutics Inc (CORT) is currently performing well based on its current performance indicators. A quick ratio of 2.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.96. Likewise, its price to free cash flow for the trailing twelve months is 42.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.15, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 2.66 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Compared to the last year’s volume of 1.41 million, its volume of 0.72 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 78.77%.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 28.38%, which indicates a significant decrease from 59.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.48 in the past 14 days, which was lower than the 3.88 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.52, while its 200-day Moving Average is $62.36. Nevertheless, the first resistance level for the watch stands at $72.65 in the near term. At $74.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $75.39. If the price goes on to break the first support level at $69.91, it is likely to go to the next support level at $68.97. Now, if the price goes above the second support level, the third support stands at $67.17.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
Market capitalization of the company is 7.51 billion based on 106,045K outstanding shares. Right now, sales total 675,040 K and income totals 141,210 K. The company made 157,210 K in profit during its latest quarter, and 20,550 K in sales during its previous quarter.
